Being TSAs that absent in normal cells, viral antigens are endowed with a powerful capability to induce cellular immune response mediated by CD4+ and CD8+ T lymphocytes to eliminate virus-associated tumor cells [60]. This evidence concerns the gene CD8A and neoplasm.